The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Therapies for Cancer Treatment Market Research Report 2025
Synopsis
In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
The global Gene Therapies for Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Therapies for Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Therapies for Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Therapies for Cancer Treatment in Cancer Research Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics and Ziopharm Oncology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Cancer Treatment.
Report Scope
The Gene Therapies for Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapies for Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapies for Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Segment by Type
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Segment by Application
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
The global Gene Therapies for Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Therapies for Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Therapies for Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Therapies for Cancer Treatment in Cancer Research Centers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics and Ziopharm Oncology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Cancer Treatment.
Report Scope
The Gene Therapies for Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapies for Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapies for Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Segment by Type
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Segment by Application
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Somatic Cell Gene Therapy (SCGT)
1.2.3 Germline Gene Therapy (GGT)
1.3 Market by Application
1.3.1 Global Gene Therapies for Cancer Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Cancer Hospitals
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapies for Cancer Treatment Market Perspective (2019-2030)
2.2 Gene Therapies for Cancer Treatment Growth Trends by Region
2.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapies for Cancer Treatment Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapies for Cancer Treatment Market Dynamics
2.3.1 Gene Therapies for Cancer Treatment Industry Trends
2.3.2 Gene Therapies for Cancer Treatment Market Drivers
2.3.3 Gene Therapies for Cancer Treatment Market Challenges
2.3.4 Gene Therapies for Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue
3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2019-2024)
3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
3.4 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
3.4.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2023
3.5 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Gene Therapies for Cancer Treatment Product Solution and Service
3.7 Date of Enter into Gene Therapies for Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapies for Cancer Treatment Breakdown Data by Type
4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2025-2030)
5 Gene Therapies for Cancer Treatment Breakdown Data by Application
5.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapies for Cancer Treatment Market Size (2019-2030)
6.2 North America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapies for Cancer Treatment Market Size by Country (2019-2024)
6.4 North America Gene Therapies for Cancer Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapies for Cancer Treatment Market Size (2019-2030)
7.2 Europe Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Country (2019-2024)
7.4 Europe Gene Therapies for Cancer Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapies for Cancer Treatment Market Size (2019-2030)
9.2 Latin America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2019-2024)
9.4 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takara Bio
11.1.1 Takara Bio Company Detail
11.1.2 Takara Bio Business Overview
11.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
11.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.1.5 Takara Bio Recent Development
11.2 Tocagen
11.2.1 Tocagen Company Detail
11.2.2 Tocagen Business Overview
11.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
11.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.2.5 Tocagen Recent Development
11.3 VBL Therapeutics
11.3.1 VBL Therapeutics Company Detail
11.3.2 VBL Therapeutics Business Overview
11.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
11.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.3.5 VBL Therapeutics Recent Development
11.4 Cold Genesys
11.4.1 Cold Genesys Company Detail
11.4.2 Cold Genesys Business Overview
11.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
11.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.4.5 Cold Genesys Recent Development
11.5 Genprex
11.5.1 Genprex Company Detail
11.5.2 Genprex Business Overview
11.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
11.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.5.5 Genprex Recent Development
11.6 Momotaro-Gene
11.6.1 Momotaro-Gene Company Detail
11.6.2 Momotaro-Gene Business Overview
11.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
11.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.6.5 Momotaro-Gene Recent Development
11.7 MultiVir
11.7.1 MultiVir Company Detail
11.7.2 MultiVir Business Overview
11.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
11.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.7.5 MultiVir Recent Development
11.8 SynerGene Therapeutics
11.8.1 SynerGene Therapeutics Company Detail
11.8.2 SynerGene Therapeutics Business Overview
11.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
11.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.8.5 SynerGene Therapeutics Recent Development
11.9 Ziopharm Oncology
11.9.1 Ziopharm Oncology Company Detail
11.9.2 Ziopharm Oncology Business Overview
11.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
11.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.9.5 Ziopharm Oncology Recent Development
11.10 Anchiano Therapeutics
11.10.1 Anchiano Therapeutics Company Detail
11.10.2 Anchiano Therapeutics Business Overview
11.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
11.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.10.5 Anchiano Therapeutics Recent Development
11.11 Celgene
11.11.1 Celgene Company Detail
11.11.2 Celgene Business Overview
11.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
11.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.11.5 Celgene Recent Development
11.12 Celsion
11.12.1 Celsion Company Detail
11.12.2 Celsion Business Overview
11.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
11.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.12.5 Celsion Recent Development
11.13 Bluebird Bio
11.13.1 Bluebird Bio Company Detail
11.13.2 Bluebird Bio Business Overview
11.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
11.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2019-2024)
11.13.5 Bluebird Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Somatic Cell Gene Therapy (SCGT)
Table 3. Key Players of Germline Gene Therapy (GGT)
Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Gene Therapies for Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gene Therapies for Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Gene Therapies for Cancer Treatment Market Share by Region (2019-2024)
Table 8. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Gene Therapies for Cancer Treatment Market Share by Region (2025-2030)
Table 10. Gene Therapies for Cancer Treatment Market Trends
Table 11. Gene Therapies for Cancer Treatment Market Drivers
Table 12. Gene Therapies for Cancer Treatment Market Challenges
Table 13. Gene Therapies for Cancer Treatment Market Restraints
Table 14. Global Gene Therapies for Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Gene Therapies for Cancer Treatment Market Share by Players (2019-2024)
Table 16. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2023)
Table 17. Ranking of Global Top Gene Therapies for Cancer Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Gene Therapies for Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapies for Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Gene Therapies for Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapies for Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Gene Therapies for Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Gene Therapies for Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Gene Therapies for Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Gene Therapies for Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Gene Therapies for Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Gene Therapies for Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Takara Bio Company Detail
Table 47. Takara Bio Business Overview
Table 48. Takara Bio Gene Therapies for Cancer Treatment Product
Table 49. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 50. Takara Bio Recent Development
Table 51. Tocagen Company Detail
Table 52. Tocagen Business Overview
Table 53. Tocagen Gene Therapies for Cancer Treatment Product
Table 54. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 55. Tocagen Recent Development
Table 56. VBL Therapeutics Company Detail
Table 57. VBL Therapeutics Business Overview
Table 58. VBL Therapeutics Gene Therapies for Cancer Treatment Product
Table 59. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 60. VBL Therapeutics Recent Development
Table 61. Cold Genesys Company Detail
Table 62. Cold Genesys Business Overview
Table 63. Cold Genesys Gene Therapies for Cancer Treatment Product
Table 64. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 65. Cold Genesys Recent Development
Table 66. Genprex Company Detail
Table 67. Genprex Business Overview
Table 68. Genprex Gene Therapies for Cancer Treatment Product
Table 69. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 70. Genprex Recent Development
Table 71. Momotaro-Gene Company Detail
Table 72. Momotaro-Gene Business Overview
Table 73. Momotaro-Gene Gene Therapies for Cancer Treatment Product
Table 74. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 75. Momotaro-Gene Recent Development
Table 76. MultiVir Company Detail
Table 77. MultiVir Business Overview
Table 78. MultiVir Gene Therapies for Cancer Treatment Product
Table 79. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 80. MultiVir Recent Development
Table 81. SynerGene Therapeutics Company Detail
Table 82. SynerGene Therapeutics Business Overview
Table 83. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product
Table 84. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 85. SynerGene Therapeutics Recent Development
Table 86. Ziopharm Oncology Company Detail
Table 87. Ziopharm Oncology Business Overview
Table 88. Ziopharm Oncology Gene Therapies for Cancer Treatment Product
Table 89. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 90. Ziopharm Oncology Recent Development
Table 91. Anchiano Therapeutics Company Detail
Table 92. Anchiano Therapeutics Business Overview
Table 93. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product
Table 94. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 95. Anchiano Therapeutics Recent Development
Table 96. Celgene Company Detail
Table 97. Celgene Business Overview
Table 98. Celgene Gene Therapies for Cancer Treatment Product
Table 99. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 100. Celgene Recent Development
Table 101. Celsion Company Detail
Table 102. Celsion Business Overview
Table 103. Celsion Gene Therapies for Cancer Treatment Product
Table 104. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 105. Celsion Recent Development
Table 106. Bluebird Bio Company Detail
Table 107. Bluebird Bio Business Overview
Table 108. Bluebird Bio Gene Therapies for Cancer Treatment Product
Table 109. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2019-2024) & (US$ Million)
Table 110. Bluebird Bio Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapies for Cancer Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene Therapies for Cancer Treatment Market Share by Type: 2023 VS 2030
Figure 3. Somatic Cell Gene Therapy (SCGT) Features
Figure 4. Germline Gene Therapy (GGT) Features
Figure 5. Global Gene Therapies for Cancer Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Gene Therapies for Cancer Treatment Market Share by Application: 2023 VS 2030
Figure 7. Cancer Research Centers Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Cancer Hospitals Case Studies
Figure 10. Others Case Studies
Figure 11. Gene Therapies for Cancer Treatment Report Years Considered
Figure 12. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Gene Therapies for Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Gene Therapies for Cancer Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Gene Therapies for Cancer Treatment Market Share by Players in 2023
Figure 16. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2023
Figure 18. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Gene Therapies for Cancer Treatment Market Share by Country (2019-2030)
Figure 20. United States Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Gene Therapies for Cancer Treatment Market Share by Country (2019-2030)
Figure 24. Germany Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Region (2019-2030)
Figure 32. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Gene Therapies for Cancer Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Gene Therapies for Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 47. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 48. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 49. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 50. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 51. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 52. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 53. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 54. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 55. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 56. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 57. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 58. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
